$3SBIO(01530.HK) rose by four percentage points, and $BRAINAURORA-B(06681.HK) also rose by four percentage points. Sentiment for innovative drugs and digital therapy in the Hong Kong stock market is quite good; however, the major pharmaceutical company in the US stock market, $Merck(MRK.US), fell by two to three percentage points instead. This round of Hong Kong stock Biotech is recovering along with the story of risk appetite and AI healthcare, while US major pharmaceutical companies are being weighed down by old issues of medical insurance and pipelines. Both are in the pharmaceutical sector, but small-cap stocks in Hong Kong are speculating on elasticity, while heavyweight stocks in the US are bearing the pressure😔